EXOC1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.6565637750432E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.47430000324778E-08 |
Normal-vs-Stage2 |
1.368510E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.521500E-03 |
Stage1-vs-Stage2 |
4.321000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.986100E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.504000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.97619698383278E-11 |
Normal-vs-AfricanAmerican |
7.187600E-02 |
Normal-vs-Asian |
1.226160E-02 |
Caucasian-vs-AfricanAmerican |
5.287800E-01 |
Caucasian-vs-Asian |
6.638000E-01 |
AfricanAmerican-vs-Asian |
6.100400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.24430000003617E-06 |
Normal-vs-Female |
1.02189999795499E-08 |
Male-vs-Female |
3.432400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.86940000000058E-05 |
Normal-vs-Extreme_Weight |
2.00989999999956E-05 |
Normal-vs-Obese |
5.97049999999655E-05 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.649000E-01 |
Normal_Weight-vs-Obese |
2.366300E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.372400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.747610E-01 |
Normal-vs-Age(41-60Yrs) |
4.21889999999703E-05 |
Normal-vs-Age(61-80Yrs) |
8.11739997441663E-09 |
Normal-vs-Age(81-100Yrs) |
4.817200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.439800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.189600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.003800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.006800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.078000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.883400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.639850E-01 |
Normal-vs-Grade 3 |
1.404400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.517200E-01 |
Grade 2-vs-Grade 4 |
1.639850E-01 |
Grade 3-vs-Grade 4 |
1.404400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.0109027210633E-11 |
Normal-vs-N1 |
8.255900E-03 |
N0-vs-N1 |
7.597200E-03 |
|
|